pharmaphorum
JANUARY 12, 2023
As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Drug diversion is the channelling of prescription drugs from a medical source into the illegal market. The post The rise of prescription drug abuse and drug diversion appeared first on.
World of DTC Marketing
OCTOBER 21, 2021
The analysis focused on Medicare Part B and Part D spending — which covers outpatient medical care and prescription drugs, respectively, — in 2017, 2018 and 2019, the researchers said. Between 2011 and 2018, cumulative spending on 44 FDA-approved oral targeted therapy drugs was $3.5
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
OCTOBER 17, 2024
However, reports and surveys say that only half of people with an epinephrine needle-injector prescription consistently carry their device, 4 and for patients and caregivers who do carry a needle-injector, more than half either delay or do not administer it in an emergency. Hand (N Y). 2007; 2(1):5-11. Derived from IQVIA Claims Data, 2023.
World of DTC Marketing
AUGUST 19, 2022
It’s no wonder that voters consistently rank bringing down prescription drug prices and other measures to reduce the cost of care as among Congress’ top priorities. Congress rightly chose to negioate drug prices for Medicare, but prescription drugs are only 10-12% of every healthcare dollar we spend. As the U.S.
Pharmaceutical Technology
JUNE 19, 2023
The FDA will make an approval decision by the new Prescription Drug User Fee Act (PDUFA) target action date of 16 September 2023. Novartis and Incyte Corp’s Jakafi was the first FDA-approved drug for the treatment of myelofibrosis in November 2011. The reason for this review extension was undisclosed in the announcement.
World of DTC Marketing
MAY 2, 2021
On a percentage basis, the figure for 2020 was Independence’s highest profit margin since 2011, records show. It’s going to affect every sector of healthcare, from prescription drugs to hospitals, and is going to squeeze profit margins. The company also did well in the stock market. How does pharma respond?
World of DTC Marketing
NOVEMBER 5, 2021
Novo Nordisk has admitted that it would not be able to keep up, adding that it would likely take until early 2022 for the supply to stabilize and that some patients “are experiencing an approximate one month or longer delay in filling prescriptions for Wegovy.”
Expert insights. Personalized for you.
92 
Let's personalize your content